Markets:

Overview

News

Currencies

International

Treasuries

Johnson & Johnson (NY:JNJ)

206.91 +0.24 (+0.12%)

Streaming Delayed Price Updated: 3:30 PM EST, Nov 26, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

99 100 Next >

Bristol-Myers Squibb (BMY) Reports Earnings Tomorrow: What To Expect

April 23, 2025

Biopharmaceutical company Bristol Myers Squibb (NYSE:BMY) will be announcing earnings results tomorrow morning. Here’s what investors should know.

Via StockStory

Trump Administration Considers Lowering US Drug Prices To International Levels: Report ↗

April 23, 2025

The Trump Administration is reportedly mulling over a policy to match U.S. drug prices with those in other developed nations.

Via Benzinga

Topics Government

JNJ Q1 Earnings: Pipeline Progress and MedTech Execution Drive Guidance Above Expectations

April 22, 2025

Multinational healthcare company Johnson & Johnson (NYSE:JNJ) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 2.4% year on year to $21.89 billion. The company’s full-year revenue...

Via StockStory

Topics Earnings World Trade

Why Johnson & Johnson, Chevron, And Flowers Foods Are Winners For Passive Income ↗

April 22, 2025

Via Benzinga

Roche Plans $50 Billion US Investment Over 5 Years With 12,000 New Jobs ↗

April 22, 2025

Roche to invest $50 billion in U.S. over five years, adding 12,000+ jobs and expanding manufacturing, R&D, and export capacity across eight states.

Via Benzinga

9 Health Care Stocks With Whale Alerts In Today's Session ↗

April 22, 2025

Via Benzinga

Johnson & Johnson (JNJ): Buy, Sell, or Hold Post Q1 Earnings?

April 22, 2025

Johnson & Johnson has been treading water for the past six months, recording a small loss of 3.8% while holding steady at $157.30. However, the stock is beating the S&P 500’s 11% decline during that...

Via StockStory

Topics Stocks

2 Recession-Proof Stocks to Buy With a Better Credit Rating Than the U.S. Government ↗

April 20, 2025

Via The Motley Fool

Topics Artificial Intelligence Economy Government

From $50 A Month To $1M Portfolio — Investor Shares Top 10 Holdings, Says 'Finally Reached $1M!' Thanks To Relentless Discipline ↗

April 19, 2025

Via Benzinga

Stocks That Weathered Past Recessions: Expert Shares Picks That Withstood Every Downturn ↗

April 19, 2025

Stock market expert Jon Erlichman recently shared a review of stock returns during the last six U.S. recessions, highlighting those that have performed well in difficult times.

Via Benzinga

The SWAN (Sleep Well At Night) Blueprint Revealed ↗

April 19, 2025

I’ve adopted “SWAN,” which stands for

Via Talk Markets

Topics Stocks / Equities

3 Top Dividend Stocks Yielding Over 3% to Buy With $500 Right Now ↗

April 19, 2025

Via The Motley Fool

Topics Bonds

ETF Shake-Up: UNH's Meltdown Meets LLY's Moonshot ↗

April 18, 2025

Healthcare sector sees volatility due to UnitedHealth's earnings disappointment, but ETFs like XLV, IHE, and XPH still show resilience and pockets of strength.

Via Benzinga

Topics ETFs

Where Will Eli Lilly Be in 5 Years? ↗

April 18, 2025

Via The Motley Fool

How To Put $100 In Your Retirement Fund Each Month With Johnson & Johnson Stock ↗

April 17, 2025

Via Benzinga

Topics Retirement

4 Reasons Johnson & Johnson Could Be the Perfect Stock to Own in Today's Turbulent Market ↗

April 17, 2025

Via The Motley Fool

Topics Earnings Government World Trade

This Super-Safe High-Yield Stock Just Extended Its Dividend Growth Streak to 63 Years in a Row ↗

April 17, 2025

Via The Motley Fool

Topics Bonds

Buy These Defensive Stocks After Beating Earnings Expectations?: ACI, JNJ ↗

April 17, 2025

Johnson & Johnson and Albertsons Companies' stock have provided a pleasant hedge against market volatility, with the S&P 500 and Nasdaq remaining near correction territory.

Via Talk Markets

Topics Stocks Stocks / Equities

Healthcare Sector Update: MEDtech And Diagnostics ↗

April 16, 2025

Amidst the tariff chaos, we may get clues from one of the most defensive sectors of the market-healthcare stocks.

Via Talk Markets

Topics ETFs Stocks / Equities World Trade

Johnson & Johnson to Participate in the 2025 RBC Capital Markets Global Healthcare Conference

April 16, 2025

From Johnson & Johnson

Via Business Wire

Trump's New Order Targets Drug Pricing Transparency And Medicare Cost Reduction ↗

April 16, 2025

Trump orders multi-part executive order to lower drug prices, reduce Medicare costs. Includes guidance on Medicare drug prices, aligning payments with hospital acquisition costs, and investigating...

Via Benzinga

Topics Government

How Is The Market Feeling About Johnson & Johnson? ↗

April 16, 2025

Via Benzinga

Johnson & Johnson's Q1 Results, FY Guidance Highlight The 'Power Of The Pharma Portfolio' ↗

April 16, 2025

Johnson & Johnson (JNJ) reported upbeat Q1 results amid an exciting earnings season, with analysts noting impressive sales and guidance from the pharma giant.

Via Benzinga

Johnson & Johnson Earnings Were More Good Than Bad—Time to Buy?

April 16, 2025

Johnson & Johnson had more good than bad; investors should look at the entire report in context before deciding if JNJ stock is a good fit for their portfolios

Via MarketBeat

Topics Government Intellectual Property World Trade

Johnson & Johnson Q1 Earnings: Strong Cancer Drug Sales, Boosts Quarterly Dividend, Anticipates Negative Currency Impact For 2025 Profit ↗

April 15, 2025

Johnson & Johnson raised its 2025 sales outlook and dividend, while Q1 results topped expectations driven by strong cancer drug performance.

Via Benzinga

2 Under-the-Radar Consumer Staples Stocks With Big Dividends

April 15, 2025

Edgewell and Kenvue are under-the-radar consumer staples stocks poised to gain as the U.S. dollar declines. Learn why they may boost your income portfolio.

Via MarketBeat

Topics ETFs Intellectual Property World Trade

Johnson & Johnson Skids Despite First-Quarter Beat, Sales Guidance Hike ↗

April 15, 2025

Johnson & Johnson stock fell alongside the broader market, despite beating first-quarter calls and hiking its sales outlook.

Via Investor's Business Daily

Topics Government Stocks

Johnson & Johnson’s Q1 Earnings Beat Estimates, 2025 Guidance Revised To Account For Intra-Cellular Therapies Acquisition: Retail’s Positive ↗

April 15, 2025

The company said the updated guidance includes costs estimated to be incurred as part of Trump’s tariffs on certain imports into the U.S.

Via Stocktwits

Topics Earnings Government World Trade

Johnson & Johnson Reports Strong Q1 Performance ↗

April 15, 2025

Johnson & Johnson's first-quarter results surpassed expectations with notable growth in sales and earnings.

Via Talk Markets

Topics Stocks / Equities

Johnson & Johnson’s (NYSE:JNJ) Q1 Sales Top Estimates, Full-Year Sales Guidance is Optimistic

April 15, 2025

Multinational healthcare company Johnson & Johnson (NYSE:JNJ) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 2.4% year on year to $21.89 billion. The company’s...

Via StockStory

Topics Intellectual Property

< Previous 1 2

...

19 20 21 22 23 24 25 26 27

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.